SlideShare ist ein Scribd-Unternehmen logo
1 von 28
Expedited Partner Therapy: Background & Current Status  Matthew Hogben PhD Centers for Disease Control and Prevention (404) 639-1833 [email_address] May 26, 2010 The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention
Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PN in the big picture CAN YOU GET INFECTED PEOPLE TREATED AT A RATE FASTER THAN THE RATE AT WHICH THEY INFECT OTHERS? Infected Patient Partner notification Partner treated Maybe!
Networks of exposure and  transmission (Artist’s conception) It’s OK, I’m not infected. . I told the guy sitting down already. I got tested and treated.
What you actually get.
Partner Referral Approaches ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
It takes a lot of (underappreciated) work. Wigfield.  Brit J Ven Dis  1972.
Case reports per 100,000 (US) STD Surveillance Report (2009), Tables 3, 13, 25. http://www.cdc.gov/std/stats08/toc.htm
www.cdc.gov/nchhstp/partners
Expedited Partner Therapy ,[object Object],[object Object],[object Object],[object Object],CDC.  Expedited partner therapy.   2006
EPT Referral Strategies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Establishing Efficacy: Key Outcomes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reinfection rates Trelle et al.  BMJ   2007. IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
Treatment rates Trelle et al.  BMJ   2007
Guidance for Use of EPT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Prevention Impact framework Effective level of  coverage Contribution of groups to population health outcome  Efficacy or  effectiveness (in targeted  groups) PREVENTION IMPACT = X X Abridged/adapted from: Aral et al.  Behavioral Interventions  2007; St. Louis & Holmes  Sexually Transmitted Diseases (3 rd  ed.) .  1999
Achieving impact with EPT COVERAGE CONTRIBUTION Partners have 20% to  75% positivity (program data)  EFFICACY Tx rate:  20% To 100% increase Reinfection:  20% to 50% decrease X X Key Issue
Patients and Physicians Discuss PDPT Probable  maximum  effect, balanced by reduced coverage
Those Barriers to Coverage ,[object Object],[object Object],[object Object],[object Object]
Protocols and other resources
“ Legal” implementation advice ,[object Object],[object Object],[object Object],[object Object]
Has coverage increased? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evolving Landscape of EPT:  Legal Status Summary   EPT is Potentially Allowable EPT is Likely Prohibited EPT is Permissible Legislation Pending CA OR WA NV NM UT AZ WY CO NB KS MO AR OK FL GA AL MS LA TX WI IA MN ID MT ND SD NC VA WV KY TN OH MI IN IL VT AK HI ME NY PA RI MA NJ CT NH SC DE DC MD ( Baltimore only) CA OR WA NV NM UT AZ WY CO NB KS MO AR OK FL GA AL MS LA TX WI IA MN ID MT ND SD NC VA WV KY TN OH MI IN IL VT AK HI ME NY PA RI MA NJ CT NH SC DE DC MD 2006 2010
Baltimore implementation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Current and near future (selected) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The bigger picture: Shifting furniture ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
All together now… Coverage Something for  everyone Contribution STD clinic Other public sector Private sector Intervention Mix  Along Continuum  of Services Efficacy Screening/Testing Patient Treatment Partner Notification & Treatment Counseling and other Interventions Follow-up Care X X
Thank You Questions and comments welcome now or later!

Weitere ähnliche Inhalte

Was ist angesagt?

American Medical Home Runs (1)
American Medical Home Runs (1)American Medical Home Runs (1)
American Medical Home Runs (1)
Jeffrey Kang
 

Was ist angesagt? (20)

Economic Impact on Minnesota's Health Care Delivery System
Economic Impact on Minnesota's Health Care Delivery SystemEconomic Impact on Minnesota's Health Care Delivery System
Economic Impact on Minnesota's Health Care Delivery System
 
Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williams
 
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltRx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
 
Achieving Universal Coverage through Comprehensive Health Reform: The Vermont...
Achieving Universal Coverage through Comprehensive Health Reform: The Vermont...Achieving Universal Coverage through Comprehensive Health Reform: The Vermont...
Achieving Universal Coverage through Comprehensive Health Reform: The Vermont...
 
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
 
Evaluating Small Group Employer Participation in New Mexico’s State Coverage ...
Evaluating Small Group Employer Participation in New Mexico’s State Coverage ...Evaluating Small Group Employer Participation in New Mexico’s State Coverage ...
Evaluating Small Group Employer Participation in New Mexico’s State Coverage ...
 
Compliance Implications Of Health Care Reform
Compliance Implications Of Health Care ReformCompliance Implications Of Health Care Reform
Compliance Implications Of Health Care Reform
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
New Update on National Health Reform: A Moving Target
New Update on National Health Reform:  A Moving TargetNew Update on National Health Reform:  A Moving Target
New Update on National Health Reform: A Moving Target
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
American Medical Home Runs (1)
American Medical Home Runs (1)American Medical Home Runs (1)
American Medical Home Runs (1)
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Rx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okesonRx16 clinical tues_330_1_lindroth_2okeson
Rx16 clinical tues_330_1_lindroth_2okeson
 
Integration of Family Planning Services into an STD Clinic Setting
Integration of Family Planning Services into an STD Clinic SettingIntegration of Family Planning Services into an STD Clinic Setting
Integration of Family Planning Services into an STD Clinic Setting
 
WGHA Discovery Series: Ali Mokdad
WGHA Discovery Series: Ali MokdadWGHA Discovery Series: Ali Mokdad
WGHA Discovery Series: Ali Mokdad
 
Julie Sonier Presents to Minnesota House
Julie Sonier Presents to Minnesota HouseJulie Sonier Presents to Minnesota House
Julie Sonier Presents to Minnesota House
 
Oregon's Coordinated Care Organizations: Governance & Impacts
Oregon's Coordinated Care Organizations: Governance & ImpactsOregon's Coordinated Care Organizations: Governance & Impacts
Oregon's Coordinated Care Organizations: Governance & Impacts
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
 

Andere mochten auch

E5 Working It Online Internet Partner Notification Jackson
E5 Working It Online Internet Partner Notification JacksonE5 Working It Online Internet Partner Notification Jackson
E5 Working It Online Internet Partner Notification Jackson
DSHS
 
HIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in TexasHIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in Texas
DSHS
 
W1 The Psychiatry of AIDS Treisman
W1 The Psychiatry of AIDS TreismanW1 The Psychiatry of AIDS Treisman
W1 The Psychiatry of AIDS Treisman
DSHS
 
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesFacing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
DSHS
 
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Jayaweera
C5 Case Study Session of Three Long-Term Survivors with HIV Disease JayaweeraC5 Case Study Session of Three Long-Term Survivors with HIV Disease Jayaweera
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Jayaweera
DSHS
 
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
DSHS
 
HIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in TexasHIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in Texas
DSHS
 
Worthey naat presentation for state conference 2010
Worthey naat presentation for state conference 2010Worthey naat presentation for state conference 2010
Worthey naat presentation for state conference 2010
DSHS
 
WEF_GHI_BMWCaseStudy_Update_2010
WEF_GHI_BMWCaseStudy_Update_2010WEF_GHI_BMWCaseStudy_Update_2010
WEF_GHI_BMWCaseStudy_Update_2010
Althea Foster
 
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Mondy
C5 Case Study Session of Three Long-Term Survivors with HIV Disease MondyC5 Case Study Session of Three Long-Term Survivors with HIV Disease Mondy
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Mondy
DSHS
 
Dallas county naat program 1
Dallas county naat program 1Dallas county naat program 1
Dallas county naat program 1
DSHS
 
Ept talk texas 5 10r
Ept talk texas 5 10rEpt talk texas 5 10r
Ept talk texas 5 10r
DSHS
 
Congenital Syphilis Epidemiology, Impact and Interventions
Congenital Syphilis Epidemiology, Impact and InterventionsCongenital Syphilis Epidemiology, Impact and Interventions
Congenital Syphilis Epidemiology, Impact and Interventions
DSHS
 
W5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection JayaweeraW5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection Jayaweera
DSHS
 

Andere mochten auch (20)

E5 Working It Online Internet Partner Notification Jackson
E5 Working It Online Internet Partner Notification JacksonE5 Working It Online Internet Partner Notification Jackson
E5 Working It Online Internet Partner Notification Jackson
 
HIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in TexasHIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in Texas
 
W1 The Psychiatry of AIDS Treisman
W1 The Psychiatry of AIDS TreismanW1 The Psychiatry of AIDS Treisman
W1 The Psychiatry of AIDS Treisman
 
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesFacing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
 
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Jayaweera
C5 Case Study Session of Three Long-Term Survivors with HIV Disease JayaweeraC5 Case Study Session of Three Long-Term Survivors with HIV Disease Jayaweera
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Jayaweera
 
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
 
HIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in TexasHIV/AIDS in Special Population Groups in Texas
HIV/AIDS in Special Population Groups in Texas
 
HIV Testing for Couples
HIV Testing for CouplesHIV Testing for Couples
HIV Testing for Couples
 
Worthey naat presentation for state conference 2010
Worthey naat presentation for state conference 2010Worthey naat presentation for state conference 2010
Worthey naat presentation for state conference 2010
 
WEF_GHI_BMWCaseStudy_Update_2010
WEF_GHI_BMWCaseStudy_Update_2010WEF_GHI_BMWCaseStudy_Update_2010
WEF_GHI_BMWCaseStudy_Update_2010
 
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Mondy
C5 Case Study Session of Three Long-Term Survivors with HIV Disease MondyC5 Case Study Session of Three Long-Term Survivors with HIV Disease Mondy
C5 Case Study Session of Three Long-Term Survivors with HIV Disease Mondy
 
Dallas county naat program 1
Dallas county naat program 1Dallas county naat program 1
Dallas county naat program 1
 
HIV Nursing
HIV NursingHIV Nursing
HIV Nursing
 
Case Study
Case StudyCase Study
Case Study
 
Ept talk texas 5 10r
Ept talk texas 5 10rEpt talk texas 5 10r
Ept talk texas 5 10r
 
HIV Nursing and Home & Community Care Conference
HIV Nursing and Home  & Community Care Conference HIV Nursing and Home  & Community Care Conference
HIV Nursing and Home & Community Care Conference
 
Congenital Syphilis Epidemiology, Impact and Interventions
Congenital Syphilis Epidemiology, Impact and InterventionsCongenital Syphilis Epidemiology, Impact and Interventions
Congenital Syphilis Epidemiology, Impact and Interventions
 
W5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection JayaweeraW5 HIV, HCV, and HBV Co-Infection Jayaweera
W5 HIV, HCV, and HBV Co-Infection Jayaweera
 
Case study HIV
Case study HIVCase study HIV
Case study HIV
 
HIV Case Study
HIV Case Study HIV Case Study
HIV Case Study
 

Ähnlich wie W7 Expedited Partner Therapy for Management of Certain Sexually Transmitted Infections Hogben

74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx
74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx
74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx
fredharris32
 
Chapter 3Public Health Data and Communications.docx
Chapter 3Public Health Data and Communications.docxChapter 3Public Health Data and Communications.docx
Chapter 3Public Health Data and Communications.docx
walterl4
 
Understanding Linkages between Governance and Health: Concepts and Evidence
Understanding Linkages between Governance and Health: Concepts and EvidenceUnderstanding Linkages between Governance and Health: Concepts and Evidence
Understanding Linkages between Governance and Health: Concepts and Evidence
HFG Project
 
Using modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategyUsing modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategy
UNITAID
 
Signature Essay Peer Review WorksheetFor this assignment, your o.docx
Signature Essay Peer Review WorksheetFor this assignment, your o.docxSignature Essay Peer Review WorksheetFor this assignment, your o.docx
Signature Essay Peer Review WorksheetFor this assignment, your o.docx
maoanderton
 
Harm reduction atma jaya
Harm reduction   atma jayaHarm reduction   atma jaya
Harm reduction atma jaya
Herrupribadi77
 
MBQIP 2011 Missouri
MBQIP 2011 Missouri MBQIP 2011 Missouri
MBQIP 2011 Missouri
learfield
 
ePatCon11: Kozloff - Introducing the Audio Health Record
ePatCon11: Kozloff - Introducing the Audio Health RecordePatCon11: Kozloff - Introducing the Audio Health Record
ePatCon11: Kozloff - Introducing the Audio Health Record
e-Patient Connections
 
Running head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docx
Running head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docxRunning head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docx
Running head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docx
toltonkendal
 

Ähnlich wie W7 Expedited Partner Therapy for Management of Certain Sexually Transmitted Infections Hogben (20)

74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx
74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx
74J Adv Pract Oncol AdvancedPractitioner.comSection Editor.docx
 
The Barriers that Prevent Certified Nurse Practitioner (CNP) Practice
The Barriers that Prevent Certified Nurse Practitioner (CNP) PracticeThe Barriers that Prevent Certified Nurse Practitioner (CNP) Practice
The Barriers that Prevent Certified Nurse Practitioner (CNP) Practice
 
Complete Medical Theories Disc.docx
Complete Medical Theories Disc.docxComplete Medical Theories Disc.docx
Complete Medical Theories Disc.docx
 
Complete Medical Theories Disc.docx
Complete Medical Theories Disc.docxComplete Medical Theories Disc.docx
Complete Medical Theories Disc.docx
 
Complete Medical Theories Disc.docx
Complete Medical Theories Disc.docxComplete Medical Theories Disc.docx
Complete Medical Theories Disc.docx
 
Richard Wolitski, Structural Interventions and the Science of HIV Prevention ...
Richard Wolitski, Structural Interventions and the Science of HIV Prevention ...Richard Wolitski, Structural Interventions and the Science of HIV Prevention ...
Richard Wolitski, Structural Interventions and the Science of HIV Prevention ...
 
Staff Meeting Breakout of HIV Prevention Topics
Staff Meeting Breakout of HIV Prevention TopicsStaff Meeting Breakout of HIV Prevention Topics
Staff Meeting Breakout of HIV Prevention Topics
 
Health reform and other policies around substance abuse treatment systems ond...
Health reform and other policies around substance abuse treatment systems ond...Health reform and other policies around substance abuse treatment systems ond...
Health reform and other policies around substance abuse treatment systems ond...
 
Chapter 3Public Health Data and Communications.docx
Chapter 3Public Health Data and Communications.docxChapter 3Public Health Data and Communications.docx
Chapter 3Public Health Data and Communications.docx
 
John Douglas: Chlamydia Prevention in the US - Update from CDC
John Douglas: Chlamydia Prevention in the US - Update from CDCJohn Douglas: Chlamydia Prevention in the US - Update from CDC
John Douglas: Chlamydia Prevention in the US - Update from CDC
 
Best Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case ManagementBest Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case Management
 
Bruno08 10 Lindelow The Impact Of Health Insurance In Rural China
Bruno08 10 Lindelow   The Impact Of Health Insurance In Rural ChinaBruno08 10 Lindelow   The Impact Of Health Insurance In Rural China
Bruno08 10 Lindelow The Impact Of Health Insurance In Rural China
 
Systematic reviews of adverse effects and other topics not – yet – covered by...
Systematic reviews of adverse effects and other topics not – yet – covered by...Systematic reviews of adverse effects and other topics not – yet – covered by...
Systematic reviews of adverse effects and other topics not – yet – covered by...
 
Understanding Linkages between Governance and Health: Concepts and Evidence
Understanding Linkages between Governance and Health: Concepts and EvidenceUnderstanding Linkages between Governance and Health: Concepts and Evidence
Understanding Linkages between Governance and Health: Concepts and Evidence
 
Using modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategyUsing modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategy
 
Signature Essay Peer Review WorksheetFor this assignment, your o.docx
Signature Essay Peer Review WorksheetFor this assignment, your o.docxSignature Essay Peer Review WorksheetFor this assignment, your o.docx
Signature Essay Peer Review WorksheetFor this assignment, your o.docx
 
Harm reduction atma jaya
Harm reduction   atma jayaHarm reduction   atma jaya
Harm reduction atma jaya
 
MBQIP 2011 Missouri
MBQIP 2011 Missouri MBQIP 2011 Missouri
MBQIP 2011 Missouri
 
ePatCon11: Kozloff - Introducing the Audio Health Record
ePatCon11: Kozloff - Introducing the Audio Health RecordePatCon11: Kozloff - Introducing the Audio Health Record
ePatCon11: Kozloff - Introducing the Audio Health Record
 
Running head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docx
Running head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docxRunning head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docx
Running head U.S. HEALTH CARE SYSTEM AND GOVERNANCE1U.S. HEA.docx
 

Mehr von DSHS

Thornton NAAT
Thornton NAATThornton NAAT
Thornton NAAT
DSHS
 
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusD1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
DSHS
 
D3 Retroviral Review Duffus
D3 Retroviral Review DuffusD3 Retroviral Review Duffus
D3 Retroviral Review Duffus
DSHS
 
C3 Neurological Complications and Treatment of HIV Clifford
C3 Neurological Complications and Treatment of HIV CliffordC3 Neurological Complications and Treatment of HIV Clifford
C3 Neurological Complications and Treatment of HIV Clifford
DSHS
 
D4 HIV Resistance Testing An Update Barnett
D4 HIV Resistance Testing An Update BarnettD4 HIV Resistance Testing An Update Barnett
D4 HIV Resistance Testing An Update Barnett
DSHS
 
C1_2 Michael Saag Chronic Disease in Longer-Term HIV Patients
C1_2 Michael Saag Chronic Disease in Longer-Term HIV PatientsC1_2 Michael Saag Chronic Disease in Longer-Term HIV Patients
C1_2 Michael Saag Chronic Disease in Longer-Term HIV Patients
DSHS
 
C6 HIV 201 Armas
C6 HIV 201 ArmasC6 HIV 201 Armas
C6 HIV 201 Armas
DSHS
 
Clanon
ClanonClanon
Clanon
DSHS
 

Mehr von DSHS (8)

Thornton NAAT
Thornton NAATThornton NAAT
Thornton NAAT
 
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusD1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
 
D3 Retroviral Review Duffus
D3 Retroviral Review DuffusD3 Retroviral Review Duffus
D3 Retroviral Review Duffus
 
C3 Neurological Complications and Treatment of HIV Clifford
C3 Neurological Complications and Treatment of HIV CliffordC3 Neurological Complications and Treatment of HIV Clifford
C3 Neurological Complications and Treatment of HIV Clifford
 
D4 HIV Resistance Testing An Update Barnett
D4 HIV Resistance Testing An Update BarnettD4 HIV Resistance Testing An Update Barnett
D4 HIV Resistance Testing An Update Barnett
 
C1_2 Michael Saag Chronic Disease in Longer-Term HIV Patients
C1_2 Michael Saag Chronic Disease in Longer-Term HIV PatientsC1_2 Michael Saag Chronic Disease in Longer-Term HIV Patients
C1_2 Michael Saag Chronic Disease in Longer-Term HIV Patients
 
C6 HIV 201 Armas
C6 HIV 201 ArmasC6 HIV 201 Armas
C6 HIV 201 Armas
 
Clanon
ClanonClanon
Clanon
 

W7 Expedited Partner Therapy for Management of Certain Sexually Transmitted Infections Hogben

  • 1. Expedited Partner Therapy: Background & Current Status Matthew Hogben PhD Centers for Disease Control and Prevention (404) 639-1833 [email_address] May 26, 2010 The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention
  • 2.
  • 3. PN in the big picture CAN YOU GET INFECTED PEOPLE TREATED AT A RATE FASTER THAN THE RATE AT WHICH THEY INFECT OTHERS? Infected Patient Partner notification Partner treated Maybe!
  • 4. Networks of exposure and transmission (Artist’s conception) It’s OK, I’m not infected. . I told the guy sitting down already. I got tested and treated.
  • 6.
  • 7. It takes a lot of (underappreciated) work. Wigfield. Brit J Ven Dis 1972.
  • 8. Case reports per 100,000 (US) STD Surveillance Report (2009), Tables 3, 13, 25. http://www.cdc.gov/std/stats08/toc.htm
  • 10.
  • 11.
  • 12.
  • 13. Reinfection rates Trelle et al. BMJ 2007. IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
  • 14. Treatment rates Trelle et al. BMJ 2007
  • 15.
  • 16. Prevention Impact framework Effective level of coverage Contribution of groups to population health outcome Efficacy or effectiveness (in targeted groups) PREVENTION IMPACT = X X Abridged/adapted from: Aral et al. Behavioral Interventions 2007; St. Louis & Holmes Sexually Transmitted Diseases (3 rd ed.) . 1999
  • 17. Achieving impact with EPT COVERAGE CONTRIBUTION Partners have 20% to 75% positivity (program data) EFFICACY Tx rate: 20% To 100% increase Reinfection: 20% to 50% decrease X X Key Issue
  • 18. Patients and Physicians Discuss PDPT Probable maximum effect, balanced by reduced coverage
  • 19.
  • 20. Protocols and other resources
  • 21.
  • 22.
  • 23. Evolving Landscape of EPT: Legal Status Summary EPT is Potentially Allowable EPT is Likely Prohibited EPT is Permissible Legislation Pending CA OR WA NV NM UT AZ WY CO NB KS MO AR OK FL GA AL MS LA TX WI IA MN ID MT ND SD NC VA WV KY TN OH MI IN IL VT AK HI ME NY PA RI MA NJ CT NH SC DE DC MD ( Baltimore only) CA OR WA NV NM UT AZ WY CO NB KS MO AR OK FL GA AL MS LA TX WI IA MN ID MT ND SD NC VA WV KY TN OH MI IN IL VT AK HI ME NY PA RI MA NJ CT NH SC DE DC MD 2006 2010
  • 24.
  • 25.
  • 26.
  • 27. All together now… Coverage Something for everyone Contribution STD clinic Other public sector Private sector Intervention Mix Along Continuum of Services Efficacy Screening/Testing Patient Treatment Partner Notification & Treatment Counseling and other Interventions Follow-up Care X X
  • 28. Thank You Questions and comments welcome now or later!

Hinweis der Redaktion

  1. This is just a slide to show that the issues around workload and burden of disease are international and date back at least 40 years! This problem illustrates the need to be able to use an alternative to provider referral in many instances.
  2. Relative burden of syphilis, GC, CT. Even assuming resources permitted some DIS-based inquiry into a proportion of GC cases (note the NY state work on core areas and the work on proportion interviewed as a predictor of subsequent incidence), there remains a large burden of infection.
  3. A reference to current CDC recommendations and a front page note on EPT and the need for patient-mediated notification and referral strategies.
  4. The point of this slide is to embed EPT into the context of existing partner services. EPT is not a categorically different approach to partner treatment; it is an enhancement of existing approaches. Grasping this point helps drive programmatic changes to guide the use of EPT in its various forms.
  5. This slide is actually more important than it might look at first glance. Reinfection is usually the outcome that we treat as most important. In partner notification, however, the key rationales are generally built around partner treatment – does anyone track index reinfection as a routine indicator of partner services success? It’s certainly not common. So examining the effect of EPT upon treatment rates is really just about as important as index patient reinfection. Looking at other behaviors lets us know something about collateral benefits and harms – unintended consequences.
  6. This and the following slide are from an independent meta-analysis. Note they included Kissinger’s (1998) study in which a provider in a practice was randomized to discuss PDPT with female patients. They also include the trich RCT (Kissinger 2006), so the overall effect, RR = 0.73, incorporates an extra infection and an arguably non-RCT. If those two studies are excluded, the effect is almost identical.
  7. The Nuwaha RCT may have an exaggerated effect size because the control arm was based on clinical attendance and the trial arm was based around index report. Note also the smaller effect for trich (Kissinger 2006).
  8. Summary of the guidance in the 2006 report.
  9. Programs should look for specific numbers in treatment improvements and partner positivity based on their own data (I apologize if this seems like a lecture or, worse, a familiar lecture!). Once programs have those estimates, however, they can work out the amount of coverage – measured as uptake? – that would provide a certain level of prevention impact.
  10. This is the study in which patients and physicians discussed PDPT. Note the effect size is bigger than the RCT estimates for CT. But what has happened to coverage? What this study adds in value is the balancing and the overlap between efficacy and coverage measurements.
  11. These are a mix of the most commonly cited issues.
  12. Peer to peer technical assistance…
  13. The paper underlying these recommendations is Hodge et al. (2008) Am J Public Health. Do check the website at www.cdc.gov/std/ept.
  14. In terms of basic availability, CDC and other efforts have been highly effective. Given the 23 states include California, Texas and New York, this almost certainly amounts to >50% of the US population.
  15. Probably outdated by now, so, again check the website!
  16. Early data from implementation in STD clinics in Baltimore. The 2010 STD Prevention conference in Atlanta in March should reveal an update to these data.
  17. A USPSTF recommendation might ease cost issues through enabling reimbursement. Certainly CDC’s priority is to get other federal agencies aligned with keeping/making EPT cost-feasible everywhere it is legal practice.
  18. One intervention at a time does look stupid when you are considering moving furniture.
  19. So we solve it all with a bigger diagram! Well, it’s a start. This is all about intervention along a continuum of services (or you could define the continuum by needs) in a way that captures the real eligible population. And then you enable policies that give 100% coverage with respect to service delivery and aim for a level of coverage measured by service uptake that results in meaningful prevention impact. Job well done and off you ride into the sunset.